Rheumatology International

, Volume 26, Issue 12, pp 1138–1142

Leflunomide increases the risk of early healing complications in patients with rheumatoid arthritis undergoing elective orthopedic surgery

  • Martin Fuerst
  • Henrike Möhl
  • Kerstin Baumgärtel
  • Wolfgang Rüther
Original Article

DOI: 10.1007/s00296-006-0138-z

Cite this article as:
Fuerst, M., Möhl, H., Baumgärtel, K. et al. Rheumatol Int (2006) 26: 1138. doi:10.1007/s00296-006-0138-z

Abstract

The aim of this object is to study whether treatment with biological or leflunomide increases the risk of wound-healing complications after elective orthopedic surgery. Between March 2002 and September 2003, 201 patients participated in this study with the following inclusion criteria: (a) Rheumatoid arthritis (RA) or psoriatic arthritis (psA), (b) therapy with: MTX, leflunomide, etanercept, infliximab, adalimumab, anakinra, (c) undergoing elective orthopedic surgery. The incidence of early postoperative wound-healing complications was compared among the different groups. In comparison with patients who received MTX therapy (n = 59), the risk of postoperative wound-healing complications in patients undergoing leflunomide therapy (n = 32) was significantly higher: 13.6% in the MTX group, 40.6% in the leflunomide group (P = 0.01). It is recommended that leflunomide medication for patients with RA undergoing elective orthopedic surgical procedure is interrupted preoperatively to reduce the risk of early wound-healing complications or infections.

Keywords

Rheumatoid arthritisWound-healingOrthopedic surgery

Copyright information

© Springer-Verlag 2006

Authors and Affiliations

  • Martin Fuerst
    • 1
    • 2
  • Henrike Möhl
    • 1
    • 2
  • Kerstin Baumgärtel
    • 1
    • 2
  • Wolfgang Rüther
    • 1
    • 2
  1. 1.Department of OrthopedicsRheumaklinik Bad BramstedtBad BramstedtGermany
  2. 2.Orthopedic DepartmentUniversity Medical Centre Hamburg-EppendorfHamburgGermany